Impact of HER2 Status Assessed by Immunohistochemistry on Treatment Response in Patients with Metastatic Breast Cancer Receiving Trastuzumab Emtansine.

Medicina (Kaunas) · 2025 · PMC12113034 · PMID 40428777

Europe PMC DOI

hedged sentence

0.3690

closest p · 7.4× alpha

0.3690

boldest claim

The sentences

did not reach statistical significancep = 0.369not close (p > 0.1)

Again, this difference did not reach statistical significance (HR: 0.93, 95% CI: 0.63–1.42; p = 0.369).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.